Recent Advances in Analytical Method Validation as per ICH Q2(R2): A Comparative Review with ICH Q2(R1)

Analytical method validation is a critical component of pharmaceutical quality assurance, ensuring the reliability and reproducibility of analytical results. The International Council for Harmonisation (ICH) guideline Q2(R1), established in 1994, has long served as the foundation for method validation across various analytical techniques. However, with evolving regulatory expectations and scientific advancements, ICH released an updated guideline Q2(R2) in March 2023, in parallel with ICH Q14, introducing a modernized approach with an emphasis on lifecycle management and enhanced method robustness. This review provides a detailed comparative analysis between ICH Q2(R1) and the new Q2(R2) guideline, highlighting key changes in validation parameters such as specificity, linearity, accuracy, precision, limit of detection (LOD), and quantitation (LOQ). The review also explores newly introduced elements including the expanded use of risk assessment tools, system suitability, enhanced method performance criteria, and the integration of Analytical Quality by Design (AQbD) principles. Furthermore, this paper discusses the practical implications of implementing Q2(R2) in pharmaceutical laboratories, including method lifecycle concepts and method performance verification. Through case studies and regulatory insights, the review aims to assist professionals in adopting a structured and risk-based approach for method validation aligned with global regulatory expectations.